meropenem hospira 500 mg pulveris injekciju vai infūziju šķīduma pagatavošanai
hospira uk limited, united kingdom - meropenēms - pulveris injekciju vai infūziju šķīduma pagatavošanai - 500 mg
ibustar 400 mg apvalkotās tabletes
berlin-chemie ag, germany - ibuprofēns - apvalkotā tablete - 400 mg
ibustar bērniem 100 mg/5 ml suspensija iekšķīgai lietošanai
berlin-chemie ag (menarini group), germany - ibuprofēns - suspensija iekšķīgai lietošanai - 20 mg/ml
ibustar bērniem 200 mg/5 ml suspensija iekšķīgai lietošanai
berlin-chemie ag (menarini group), germany - ibuprofēns - suspensija iekšķīgai lietošanai - 40 mg/ml
vydura
pfizer europe ma eeig - rimegepant - migrēnas traucējumi - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.
ibumetin express 400 mg mīkstās kapsulas
orifarm healthcare a/s, denmark - ibuprofēns - kapsula, mīkstā - 400 mg
rasilamlo
novartis europharm ltd - aliskiren, amlodipine - hipertensija - agents, kas iedarbojas uz renīna-angiotenzīna sistēmu - rasilamlo tiek norādīts būtisks hipertensija pieaugušiem pacientiem, kuru asinsspiediens netiek pienācīgi kontrolēts ar aliskiren vai amlodipīnu, ko lieto vienus pašus ārstēšanai.
korejas ŽeŅšeŅa tĒja cits, granulas
dongwon korean ginseng co., ltd. co., ltd., f1& head: 59-20, changkwan 2 gil, jincheon-eub, jincheon-gun, chung buk; f2: 87 - cits, granulas
edistride
astrazeneca ab - dapagliflozin propāndiols monohidrāts - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - cukura diabēts - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. papildus citām zālēm, lai ārstētu 2. tipa cukura diabētu. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 un 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.
entresto
novartis europharm limited - sacubitril, valsartan - sirdskaite - angiotensīna ii antagonisti, citas kombinācijas, līdzekļi, kas iedarbojas uz renin-angiotensīna sistēmu - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.